Second Patent Issued to Strongbridge’s Recorlev for Treatment of Cushing’s Syndrome
News
Strongbridge Biopharma recently received a second patent from the U.S. Patent and Trademark Office covering the use of Recorlev (levoketoconazole) for the treatment of Cushing’s syndrome. The patent (No. 9,918,984) is titled “Methods ... Read more